Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 2
1936 1
1940 1
1946 1
1947 2
1948 3
1950 1
1961 5
1962 2
1963 2
1964 4
1965 2
1966 4
1967 1
1968 2
1969 2
1970 3
1971 2
1972 2
1973 1
1974 3
1975 3
1976 1
1977 4
1978 3
1979 1
1980 1
1981 1
1982 5
1985 4
1986 5
1987 5
1988 10
1989 15
1990 15
1991 19
1992 24
1993 19
1994 29
1995 14
1996 34
1997 23
1998 34
1999 42
2000 46
2001 65
2002 71
2003 93
2004 117
2005 153
2006 174
2007 205
2008 220
2009 278
2010 309
2011 377
2012 405
2013 461
2014 435
2015 472
2016 498
2017 562
2018 551
2019 528
2020 581
2021 573
2022 538
2023 138
Text availability
Article attribute
Article type
Publication date

Search Results

7,224 results
Results by year
Filters applied: . Clear all
Page 1
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆.
Niu J, Maurice-Dror C, Lee DH, Kim DW, Nagrial A, Voskoboynik M, Chung HC, Mileham K, Vaishampayan U, Rasco D, Golan T, Bauer TM, Jimeno A, Chung V, Chartash E, Lala M, Chen Q, Healy JA, Ahn MJ. Niu J, et al. Among authors: lee dh. Ann Oncol. 2022 Feb;33(2):169-180. doi: 10.1016/j.annonc.2021.11.002. Epub 2021 Nov 18. Ann Oncol. 2022. PMID: 34800678 Free article. Clinical Trial.
Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
Shin MJ, Park JY, Lee DH, Khang D. Shin MJ, et al. Among authors: lee dh. Int J Nanomedicine. 2021 Dec 31;16:8485-8507. doi: 10.2147/IJN.S334298. eCollection 2021. Int J Nanomedicine. 2021. PMID: 35002240 Free PMC article. Review.
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors.
Cho BC, Han JY, Kim SW, Lee KH, Cho EK, Lee YG, Kim DW, Kim JH, Lee GW, Lee JS, Shim BY, Kim JS, Chun SH, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Lee Y, Lee DH, Kang JA, Lee N, Kwon MJ, Espenschied C, Yablonovitch A, Ahn MJ. Cho BC, et al. Among authors: lee dh. J Thorac Oncol. 2022 Apr;17(4):558-567. doi: 10.1016/j.jtho.2021.11.025. Epub 2021 Dec 24. J Thorac Oncol. 2022. PMID: 34958928 Free article. Clinical Trial.
A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS, Kim SG, Kim YS, Jang SH, Kwon Y, Choi D, Huh T, Moon E, Ahn E, Seong JK, Kweon HS, Hwang GS, Lee DH, Cho KW, Koo SH. Han HS, et al. Among authors: lee dh. Mol Metab. 2022 Jan;55:101402. doi: 10.1016/j.molmet.2021.101402. Epub 2021 Nov 24. Mol Metab. 2022. PMID: 34838715 Free PMC article.
7,224 results